This inventor holds 1 USPTO granted patent. Top assignee: Abbott Laboratories Corporation. Active years: 2008.
Company Filing History:
Years Active: 2008
Title: The Innovative Contributions of Andreas Loew
Introduction
Andreas Loew is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of biochemistry, particularly in the study of Lck, a protein involved in immune response. His work has implications for the development of new therapeutic agents.
Latest Patents
Andreas Loew holds a patent titled "Method of identifying inhibitors of Lck." This invention relates to polypeptides that comprise the ligand binding domain of Lck, along with crystalline forms of these polypeptides. The patent outlines the use of these crystalline forms to determine the three-dimensional structure of the catalytic domain of Lck. Furthermore, it discusses methods for designing and identifying potential inhibitors of Lck activity, which could lead to the development of selective inhibitors that target the binding of native substrates to the Lck catalytic domain.
Career Highlights
Loew is associated with Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to focus on innovative research that bridges the gap between basic science and practical applications in medicine. His patent reflects his commitment to advancing the understanding of protein interactions and their implications for drug design.
Collaborations
Andreas Loew has collaborated with notable colleagues, including Kurt Ritter and Adelaine Leung. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Andreas Loew's contributions to the field of biochemistry, particularly through his patent on Lck inhibitors, highlight his innovative spirit and dedication to advancing medical science. His work continues to pave the way for new therapeutic strategies.